{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:55:28Z","timestamp":1772117728664,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd010404","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,12,20]],"date-time":"2014-12-20T00:00:00Z","timestamp":1419033600000}}],"reference-count":73,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010404.pub2","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T18:00:14Z","timestamp":1419012014000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection"],"prefix":"10.1002","volume":"2014","author":[{"given":"Tim J","family":"Benstead","sequence":"first","affiliation":[{"name":"Dalhousie University; Department of Medicine, Division of Neurology; Room 3828 Halifax Infirmary, 1796 Summer Street Halifax NS Canada B3H 3A7"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin H","family":"Chalk","sequence":"additional","affiliation":[{"name":"McGill University; Departments of Medicine and Neurology & Neurosurgery; Montreal General Hospital - Room L7-313 1650 Cedar Avenue Montreal QC Canada H3G 1A4"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie E","family":"Parks","sequence":"additional","affiliation":[{"name":"Dalhousie University; Department of Medicine, Division of Neurology; Room 3828 Halifax Infirmary, 1796 Summer Street Halifax NS Canada B3H 3A7"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,12,20]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD010404.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood-2009-10-245878","article-title":"Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study","volume":"116","author":"Dammacco","year":"2010","journal-title":"Blood"},{"issue":"Suppl 10","key":"10.1002\/14651858.CD010404.pub2-BIB0002|cit2","first-page":"2201","article-title":"A randomized, controlled, multicenter phase III study of the efficacy and safety of rituximab (RTX) monotherapy versus the best available treatment in patients with mixed cryoglobulinemia syndrome","volume":"62","author":"Vita","year":"2010","journal-title":"Arthritis and Rheumatism"},{"issue":"3","key":"10.1002\/14651858.CD010404.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.34331","article-title":"A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis","volume":"64","author":"Vita","year":"2012","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD010404.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V81.5.1132.1132","article-title":"Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial","volume":"81","author":"Ferri","year":"1993","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD010404.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/art.34322","article-title":"A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis","volume":"64","author":"Sneller","year":"2012","journal-title":"Arthritis and Rheumatism"},{"issue":"11","key":"10.1002\/14651858.CD010404.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00042737-199711000-00008","article-title":"Effects of long-term course of alpha-interferon in patients with chronic hepatitis C associated to mixed cryoglobulinaemia","volume":"9","author":"Adinolfi","year":"1997","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD010404.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/mus.20184","article-title":"Peripheral neuropathy in hepatitis-related mixed cryoglobulinemia: electrophysiologic follow-up study","volume":"31","author":"Ammendola","year":"2005","journal-title":"Muscle & Nerve"},{"issue":"5","key":"10.1002\/14651858.CD010404.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1212\/01.wnl.0000233889.07772.76","article-title":"Peripheral neurotoxicity of pegylated interferon alpha: a prospective study in patients with HCV","volume":"67","author":"Briani","year":"2006","journal-title":"Neurology"},{"issue":"9","key":"10.1002\/14651858.CD010404.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1046\/j.1365-2036.1999.00581.x","article-title":"Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia","volume":"13","author":"Calleja","year":"1999","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD010404.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s00415-009-5072-z","article-title":"Rituximab in cryoglobulinemic peripheral neuropathy","volume":"256","author":"Cavallo","year":"2009","journal-title":"Journal of Neurology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010404.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/S1590-8658(07)80024-7","article-title":"Rituximab in mixed cryoglobulinemia: increased experience and perspectives","volume":"39","author":"Vita","year":"2007","journal-title":"Digestive and Liver Disease"},{"issue":"1","key":"10.1002\/14651858.CD010404.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.autrev.2011.07.005","article-title":"Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature","volume":"11","author":"Ferri","year":"2011","journal-title":"Autoimmunity Reviews"},{"issue":"2","key":"10.1002\/14651858.CD010404.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1212\/WNL.46.2.588-b","article-title":"Treatment of cryoglobulinemic neuropathy with alpha-interferon","volume":"46","author":"Ghini","year":"1996","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD010404.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF02990568","article-title":"Long-term results regarding the use of recombinant interferon alpha-2b in the treatment of II type mixed essential cryoglobulinemia","volume":"12","author":"Lauta","year":"1995","journal-title":"Medical Oncology (Northwood, London, England)"},{"issue":"5","key":"10.1002\/14651858.CD010404.pub2-BIB0015|cit15","first-page":"345","article-title":"Peripheral neuropathy and hepatitis C virus","volume":"9","author":"Lidove","year":"2002","journal-title":"Hepato-Gastro"},{"issue":"Suppl 13","key":"10.1002\/14651858.CD010404.pub2-BIB0016|cit16","first-page":"S181","article-title":"Effects of two different alpha-interferon regimens on clinical and virological findings in mixed cryoglobulinemia","volume":"13","author":"Mazzaro","year":"1995","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"Suppl 13","key":"10.1002\/14651858.CD010404.pub2-BIB0017|cit17","first-page":"S175","article-title":"Interferon in the treatment of mixed cryoglobulinemia","volume":"13","author":"Migliaresi","year":"1995","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1002\/14651858.CD010404.pub2-BIB0018|cit18","first-page":"35","article-title":"Interferon-alpha in mixed cryoglobulinaemia patients: a randomized, crossover-controlled trial","volume":"24","author":"Penny","year":"1993","journal-title":"Interferons Cytokines"},{"issue":"3","key":"10.1002\/14651858.CD010404.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood-2009-11-253948","article-title":"Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease","volume":"116","author":"Petrarca","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD010404.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood-2009-10-248518","article-title":"Rituximab plus peg-interferon-alpha\/ribavirin compared with peg-interferon-alpha\/ribavirin in hepatitis C-related mixed cryoglobulinemia","volume":"116","author":"Saadoun","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD010404.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/annrheumdis-2012-202770","article-title":"Peg-IFN\u03b1\/ribavirin\/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24","volume":"73","author":"Saadoun","year":"2014","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"10","key":"10.1002\/14651858.CD010404.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","article-title":"Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20","volume":"101","author":"Sansonno","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD010404.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1473-0502(03)00055-7","article-title":"Immunoadsorption apheresis (Selesorb) in the treatment of chronic hepatitis C virus-related type 2 mixed cryoglobulinemia","volume":"28","author":"Stefanutti","year":"2003","journal-title":"Transfusion and Apheresis Science"},{"issue":"6","key":"10.1002\/14651858.CD010404.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jca.20222","article-title":"Immunoadsorption apheresis and immunosuppressive drug therapy in the treatment of complicated HCV-related cryoglobulinemia","volume":"24","author":"Stefanutti","year":"2009","journal-title":"Journal of Clinical Apheresis"},{"issue":"25","key":"10.1002\/14651858.CD010404.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1182\/blood-2011-12-396028","article-title":"Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey","volume":"119","author":"Terrier","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1002\/14651858.CD010404.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010404.pub2-BIB0027|cit27","doi-asserted-by":"crossref","unstructured":"Zeuzem S Nelson DR Andreone P Ferenci P Herring R Jensen DM Phase IIB study of balapiravir (RG1626; nucleoside analogue inhibitor of HCV polymerase) plus peg-interferon alfa-2a (40 KD) and ribavirin for CHC genotype 1: final results Journal of Hepatology 2010 S302 3","DOI":"10.1016\/S0168-8278(10)60780-5"},{"issue":"9","key":"10.1002\/14651858.CD010404.pub2-BIB0028|cit28","first-page":"2172","article-title":"Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha","volume":"27","author":"Zuckerman","year":"2000","journal-title":"Journal of Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD010404.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/NRL.0b013e31815fa594","article-title":"Neurologic complications of hepatitis C","volume":"14","author":"Acharya","year":"2008","journal-title":"The Neurologist"},{"issue":"17","key":"10.1002\/14651858.CD010404.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","article-title":"Epidemiology of hepatitis C virus infection","volume":"13","author":"Alter","year":"2007","journal-title":"World Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD010404.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0035-9203(97)90070-5","article-title":"Hepatitis C antibody prevalence in blood donors in different governorates in Egypt","volume":"91","author":"Arthur","year":"1997","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"7454","key":"10.1002\/14651858.CD010404.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"1-2","key":"10.1002\/14651858.CD010404.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0165-5728(96)00191-9","article-title":"T-cell-mediated epineurial vasculitis and humoral-mediated microangiopathy in cryoglobulinemic neuropathy","volume":"73","author":"Bonetti","year":"1997","journal-title":"Journal of Neuroimmunology"},{"issue":"6","key":"10.1002\/14651858.CD010404.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s004280050380","article-title":"Hepatitis C virus infection of peripheral nerves in type II cryoglobulinaemia","volume":"434","author":"Bonetti","year":"1999","journal-title":"Virchows Archiv : an International Journal of Pathology"},{"key":"10.1002\/14651858.CD010404.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000052074","article-title":"NIS-LL: the primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy","volume":"41 Suppl 1","author":"Bril","year":"1999","journal-title":"European Neurology"},{"issue":"1","key":"10.1002\/14651858.CD010404.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00005792-200001000-00005","article-title":"Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C","volume":"79","author":"Cacoub","year":"2000","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1002\/14651858.CD010404.pub2-BIB0037|cit37","first-page":"109","article-title":"Systemic vasculitis in patients with hepatitis C","volume":"28","author":"Cacoub","year":"2001","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD010404.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1097\/01.aids.0000192081.33938.2f","article-title":"Hepatitis C virus infection and mixed cryoglobulinaemia vasculitis: a review of neurological complications","volume":"19 Suppl 3","author":"Cacoub","year":"2005","journal-title":"AIDS"},{"issue":"3","key":"10.1002\/14651858.CD010404.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.20958","article-title":"PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis","volume":"52","author":"Cacoub","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"10","key":"10.1002\/14651858.CD010404.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood.V90.10.3865","article-title":"Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection","volume":"90","author":"Casato","year":"1997","journal-title":"Blood"},{"issue":"7","key":"10.1002\/14651858.CD010404.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1212\/WNL.32.7.725","article-title":"The pathogenesis of cryoglobulinemic neuropathy","volume":"32","author":"Chad","year":"1982","journal-title":"Neurology"},{"issue":"8","key":"10.1002\/14651858.CD010404.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/WNL.53.8.1660","article-title":"Total neuropathy score: validation and reliability study","volume":"53","author":"Cornblath","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD010404.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/jnnp.37.1.82","article-title":"Mixed or immune complex cryoglobulinaemia and neuropathy","volume":"37","author":"Cream","year":"1974","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD010404.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/gut.45.1.122","article-title":"Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus","volume":"45","author":"Cresta","year":"1999","journal-title":"Gut"},{"issue":"11","key":"10.1002\/14651858.CD010404.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1056\/NEJMra1208642","article-title":"Therapy for hepatitis c virus-related cryoglobulinemic vasculitis","volume":"369","author":"Dammacco","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"7121","key":"10.1002\/14651858.CD010404.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1136\/bmj.315.7121.1533","article-title":"Meta-analysis: principles and procedures","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD010404.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s12072-011-9303-x","article-title":"Hepatitis C virus (genotype 4)-associated mixed cryoglobulinemia vasculitis: effects of antiviral treatment","volume":"6","author":"Khayat","year":"2012","journal-title":"Hepatology International"},{"issue":"11","key":"10.1002\/14651858.CD010404.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2337\/diacare.17.11.1281","article-title":"A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy","volume":"17","author":"Feldman","year":"1994","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1002\/14651858.CD010404.pub2-BIB0049|cit49","first-page":"889","article-title":"Peripheral neuropathy in mixed cryoglobulinemia: Clinical and electrophysiologic investigations","volume":"19","author":"Ferri","year":"1992","journal-title":"Journal of Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD010404.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/0091270003258669","article-title":"Global burden of disease (GBD) for hepatitis C","volume":"44","author":"Global Burden of Hepatitis C Working Group","year":"2004","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD010404.pub2-BIB0051|cit51","unstructured":"Jan Brozek, Andrew Oxman, Holger Sch\u00fcnemann GRADEpro 2008"},{"key":"10.1002\/14651858.CD010404.pub2-BIB0052|cit52","unstructured":"Higgins JP Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"5","key":"10.1002\/14651858.CD010404.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2169\/internalmedicine.42.377","article-title":"Chronic hepatitis C infection and peripheral neuropathy; is mixed cryoglobulinemia really important?","volume":"42","author":"Kanda","year":"2003","journal-title":"Internal Medicine"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD010404.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/jhep.2002.35620","article-title":"Hepatitis C, cryoglobulinemia, and cirrhosis: A meta-analysis","volume":"36","author":"Kayali","year":"2002","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD010404.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","article-title":"The global burden of hepatitis C","volume":"29 Suppl 1","author":"Lavanchy","year":"2009","journal-title":"Liver International"},{"issue":"6","key":"10.1002\/14651858.CD010404.pub2-BIB0056|cit56","first-page":"933","article-title":"Efficacy and safety of peginterferon alfa-2b plus ribavirin for HCV-positive mixed cryoglobulinemia: A multicentre open-label study","volume":"29","author":"Mazzaro","year":"2011","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD010404.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1212\/WNL.54.4.943","article-title":"Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group","volume":"54","author":"Merkies","year":"2000","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD010404.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jnnp.72.5.596","article-title":"Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies","volume":"72","author":"Merkies","year":"2002","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"Pt 3","key":"10.1002\/14651858.CD010404.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/brain\/111.3.541","article-title":"Cryoglobulinaemic neuropathy. A clinical, morphological and immunocytochemical study of 8 cases","volume":"111","author":"Nemni","year":"1988","journal-title":"Brain"},{"issue":"9","key":"10.1002\/14651858.CD010404.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1136\/jnnp.74.9.1267","article-title":"Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia","volume":"74","author":"Nemni","year":"2003","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD010404.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.autrev.2011.01.008","article-title":"Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients","volume":"10","author":"Pietrogrande","year":"2011","journal-title":"Autoimmunity Reviews"},{"key":"10.1002\/14651858.CD010404.pub2-BIB0062|cit62","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 2014"},{"issue":"11","key":"10.1002\/14651858.CD010404.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/art.22168","article-title":"Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term followup study","volume":"54","author":"Saadoun","year":"2006","journal-title":"Arthritis and Rheumatism"},{"issue":"10","key":"10.1002\/14651858.CD010404.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/ard.2007.081653","article-title":"Rituximab combined with peg-interferon-ribavirin in refractory hepatitic C virus-associated cryoglobulinaemia vasculitis","volume":"67","author":"Saadoun","year":"2008","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"5","key":"10.1002\/14651858.CD010404.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/jnnp.2005.081570","article-title":"Prevalence and characteristics of peripheral neuropathy in hepatitis C virus population","volume":"77","author":"Santoro","year":"2006","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD010404.pub2-BIB0066|cit66","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD010404.pub2-BIB0067|cit67","first-page":"395","article-title":"Cryoglobulins: an important but neglected clinical test","volume":"36","author":"Shihabi","year":"2006","journal-title":"Annals of Clinical and Laboratory Science"},{"issue":"3","key":"10.1002\/14651858.CD010404.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1529-8027.2008.00180.x","article-title":"The Utah Early Neuropathy Scale: A sensitive clinical scale for early sensory predominant neuropathy","volume":"13","author":"Singleton","year":"2008","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"1-2","key":"10.1002\/14651858.CD010404.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2008.12.008","article-title":"Interferon alpha and neuromuscular disorders","volume":"207","author":"St\u00fcbgen","year":"2009","journal-title":"Journal of Neuroimmunology"},{"issue":"2","key":"10.1002\/14651858.CD010404.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ana.410080208","article-title":"Cryoglobulinemic neuropathy: a pathological study","volume":"8","author":"Vallat","year":"1980","journal-title":"Annals of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD010404.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"Swieten","year":"1988","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD010404.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00415-010-5686-1","article-title":"Sensory neuropathy in patients with cryoglobulin negative hepatitis-C infection","volume":"258","author":"Yoon","year":"2011","journal-title":"Journal of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD010404.pub2-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010404","article-title":"Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection","author":"Benstead","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010404.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:40:36Z","timestamp":1747222836000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010404.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,20]]},"references-count":73,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010404.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725283677.793502637","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,20]]}}}